Antiarrhythmic actions of coronary vasodilator agents papaverine, dioxyline and verapamil.
D031841:Aconitum; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000139:chemically induced / Q000188:drug therapy*; D003331:Coronary Vessels; D004285:Dogs; D004837:Epinephrine; D005260:Female; D006325:Heart Atria; D006352:Heart Ventricles; D006838:Hydrocarbons; D007546:Isoquinolines / Q000627:therapeutic use*; D008297:Male; D009570:Nitriles / Q000627:therapeutic use*; D010042:Ouabain; D010208:Papaverine / Q000627:therapeutic use*; D011802:Quinidine / Q000627:therapeutic use*; D013610:Tachycardia / Q000139:chemically induced / Q000188:drug therapy; D014665:Vasodilator Agents / Q000627:therapeutic use*; D014700:Verapamil / Q000627:therapeutic use
D000889:Anti-Arrhythmia Agents; D006838:Hydrocarbons; D007546:Isoquinolines; D009570:Nitriles; D014665:Vasodilator Agents; D010042:Ouabain; D014700:Verapamil; D010208:Papaverine; D011802:Quinidine; D004837:Epinephrine